CEimpact Podcast

The standard of care for pancreatitis has been aggressive (liters) of intravenous fluids. New data suggests that this level of fluid resuscitation may not be needed – and possibly harmful. Join host Geoff Wall as he evaluates the role of fluids in pancreatitis treatment.

The GameChanger
In patients with mild disease, moderate fluid resuscitation is safer than aggressive fluid use.

Show Segments
00:00 - Introduction
01:17 - Current Standard of Care
04:37 - The WATERFALL Study
10:20 - GameChanger: Study Findings
16:00 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

• Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis

Redeem your CPE or CME here

• CPE (Pharmacist) 
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current standard of care for treating pancreatitis
2. Describe the findings of the WATERFALL study and how it applies to patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-440-H04-P
Initial release date: 12/09/2022
Expiration date: 12/09/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

A recent study showed that ethanol abuse is a leading cause of death in young adults in the US and that rates of alcoholism have increased. Join host Geoff Wall as he reviews the treatment of ethanol withdrawal.

The GameChanger
Ethanol abuse is a leading cause of death in young adults. Fortunately, multiple therapies exist to treat hospitalized patients with acute ethanol withdrawal. 

Show Segments
00:00 - Introductions
01:44 - Alcohol Abuse and Mortality in the United States
03:38 - GameChanger: Study Results
06:15 - Connecting to Practice: Alcohol Withdrawl Syndrome Treatment
24:11 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

• Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019
• Management of Alcohol Withdrawal in the Emergency Department: Current Perspectives

Redeem your CPE or CME here

• CPE (Pharmacist)  
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the epidemiology of alcohol abuse and mortality in the United States
2. Describe treatment of the hospitalized patient with acute ethanol abuse

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-435-H04-P
Initial release date: 12/06/2022
Expiration date: 12/06/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Obesity is still at epidemic levels in the United States. More and more medications are coming to market to help with weight loss. The American Gastroenterological Association (AGA) just released guidelines for evidence-based care for persons with obesity.

The GameChanger
Guidelines are now available for the treatment of obesity. The evidence-based recommendations will help providers determine appropriate therapy for persons with obesity.

Show Segments
00:00 - Introduction
01:16 - The Obesity Epidemic in the United States
05:57 - Looking at the AGA Obesity Guidelines
16:30 - AGA Obesity Guidelines: Combination Products
26:25 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology

Redeem your CPE or CME here

• CPE (Pharmacist) 
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the framework of the 2022 AGA obesity guidelines
2. Apply the guideline recommendations to persons with obesity

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-428-H01-P
Initial release date: 11/28/2022
Expiration date: 11/28/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Health Equity is achieved when every person has the opportunity to attain their full health potential and no one is disadvantaged. Oftentimes, this is evaluated and addressed through resolving social determinants of health. A recent study evaluated the impact of food insecurity on cardiovascular outcomes. Join host, Geoff Wall, as he discusses how healthcare teams can address food insecurity with guest Jake Galdo.

The GameChanger
Increased screening, identification, and referrals are needed to address the negative consequences of food insecurity on cardiovascular outcomes.

Show Segments
00:00 - Introductions
00:55 - Background on the Issue
05:45 - Looking at the Study
13:00 - The GameChanger: Results of the Study
15:40 - Connecting to Practice
26:54 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Director, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

References and Resources

Food Insecurity Among Individuals With Cardiovascular Disease and Cardiometabolic Risk Factors Across Race and Ethnicity

Redeem your CPE or CME here

• CPE (Pharmacist)
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the prevalence of food insecurity in patients with cardiovascular disease
2. Discuss the role of the healthcare team in addressing food insecurity

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-425-H04-P
Initial release date: 11/16/2022
Expiration date: 11/16/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Whose job is it to teach risk management principles to pharmacy learners? Sure – they have to take a law course as part of their curricular requirements, but how much does that mean to them until they are in real life situations as part of their IPPEs, APPEs, or residency? As preceptors, it’s important that we not only recognize and manage the legal risks of welcoming pharmacy learners within our pharmacy practice but also that we are prepared to teach practical concepts such as risk management in addition to developing their clinical skills. Listen to this episode where we talk with David Brushwood, a well-known expert, and educator in the practical and professional aspects of risk management and pharmacy law.

Host
Kathy Schott, PhD
CEimpact
 
Guests
David Brushwood, RPh, JD
Senior Lecturer, University of Wyoming School of Pharmacy
Professor Emeritus, University of Florida
Content Development, CEimpact

David Brushwood graduated with degrees in pharmacy and law from the University of Kansas.  He practiced both professions prior to entering academia.  David retired from the University of Florida, College of Pharmacy, in 2014 where he is currently Professor Emeritus of Pharmaceutical Outcomes and Policy.  In 2015, David joined the faculty at the University of Wyoming, School of Pharmacy, and he serves there as a Senior Lecturer teaching online courses in the Master of Science in Health Services Administration program.  David is a pharmacy law content developer with CEimpact, where he produces educational programs for pharmacists, pharmacy technicians, and pharmacy students. David’s primary research interests are pain management policy, patient safety regulation, and pharmacist professional responsibility.

 Get CE
Click here to access the course

CE Information

At the end of this course, preceptors will be able to:

1.     Describe situations where exposure to malpractice liability may occur for preceptors during experiential learning

2.     Discuss techniques for teaching risk management to pharmacy learners in the experiential learning setting

 UAN: 0107-0000-22-422-H99-P
 Release Date: 11/16/2022
 Expiration Date: 11/16/2025
The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

• Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
• Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

 Want more information on this and related topics? 

• Avoiding Malpractice Liability with Effective Teaching Strategies
• FERPA: A Guide for Preceptors
• Advanced Certificates in Risk Management:
  • For IPPE Students
  • For APPE Students
  • For Pharmacy Residents
• Pharmacist-In-Charge Bootcamp

Follow CEimpact on Social Media:
LinkedIn
Instagram

Various SGLT-2s have been shown to improve cardiovascular outcomes in the presence and absence of diabetes. A recent study evaluated the effect of dapagliflozin in mildly reduced or preserved ejection fraction. Join host, Geoff Wall, as he discusses how SGLT-2s may be a real GameChanger in heart failure with expert, Troy Lynn Lewis.

The GameChanger
The data showcasing the benefits of SGLT-2s in patients with heart failure with or without diabetes continues to grow. Dapagliflozin may be another treatment option for persons with heart failure.

Are you a CEimpact Member? Members get exclusive access to new courses and CE for this podcast. Over 62 hours of new CE each year + access to hundreds more on demand. Go to www.CEimpact.com to become a member today!

Show Segments
00:00 - Introductions
01:55 - The DELIVER Study
14:10 - GameChanger: DELIVER Discussion
20:44 - Connecting to Practice: Patient Considerations
26:11 - Closing Remarks


Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Troy Lynn Lewis, PharmD, BC-ADM
Assistant Professor, Pharmacy Practice
Wilkes University

References and Resources
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Redeem your CPE or CME here

• CPE (Pharmacist) 
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the role of SGLT-2s in heart failure management
2. Discuss the results of the DELIVER trial

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-414-H01-P
Initial release date: 11/14/2022
Expiration date: 11/14/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Less than ten percent of people filled a glucagon prescription after a hospitalization due to hypoglycemia. In the past few years, a slew of new glucagon products have come to market. Join host, Geoff Wall, as he discusses how to optimize glucagon therapy with diabetes expert, Jamie Pitlick.

The GameChanger
Despite glucagon products being proven safe and effective, they are severely under-prescribed and underutilized.  Patients that are at risk for level 2 or 3 hypoglycemia should be prescribed glucagon.

Did you know poisons have been used as murder weapons throughout human history? Join us on November 10th at 7 PM CT for a free, live CE on Murder with Medications exclusively on the CEimpact App. It's free to join! You'll learn about medical professionals who used their access to medications to commit murder. It's fascinating and unimaginable. Sign up here!

Show Segments
00:00 - Introductions

01:54 - The Risk of Hypoglycemia

10:45 - GameChanger: New Glucagon Products

20:40 - Connecting to Practice: What Practitioners Should Know

25:11 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
Jamie Pitlick, Pharm.D., BCPS, BC-ADM
Associate Professor, Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

References and Resources

1. GlucaGen - Plainsboro, NJ: Novo Nordisk.  Revised in March 2021. 
2. Glucagon - Indianapolis, IN. Eli Lily USA. 
3. Zegalogue - Denmark: Zealand Pharma. Revised April 2021. 
4. Baqsimi - Indianapolis, IN: Eli Lily.  Revised October, 2020. 
5. GVOKE - Chicago, IL: Xeris Pharmaceuticals.   Revised August 2021

Redeem your CPE or CME here

• CPE (Pharmacist)
• CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the risk of hypoglycemia for patients with diabetes
2. Describe the differences in the glucagon products on the market in the US

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-402-H01-P
Initial release date: 11/07/2022
Expiration date: 11/07/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The GRADE studies evaluated the pharmacotherapy of diabetes after initiation of metformin – for both micro- and macrovascular outcomes. Join host, Geoff Wall, and guest Jake Galdo as they examine these studies to determine if they are GameChangers in diabetes management.

The GameChanger
Insulin glargine and liraglutide had the biggest decrease in A1c; however, many patients still did not reach goal targets. Minor differences in microvascular and macrovascular outcomes were observed.

Show Segments
00:00 - Introductions

1:40 - The GRADE Studies

12:02 - Glycemic Outcomes

16:08 - Microvascular and Cardiovascular Outcomes

21:10 - The GameChanger: Selecting a Second Medication

27:18 - Connecting to Practice: Realistic Diabetes Care

33:17 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Director, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad


References and Resources

• Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes
• Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular 

Redeem your CPE or CME here

• CPE (Pharmacist)
• CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Select a second medication after metformin in a patient with type 2 diabetes based on the data from the GRADE studies
2. Discuss the results of the GRADE studies

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-401-H01-P
Initial release date: 10/31/2022
Expiration date: 10/31/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The role of anticoagulant therapy (warfarin) with antiplatelet therapy (aspirin) is a balance of risk versus benefit. However, reducing risk by de-prescribing is often avoided due to hypothetical efficacy reduction. Join host, Geoff Wall, as he evaluates de-prescribing aspirin in patients taking anticoagulants.

The GameChanger
Anticoagulant therapy provides as good or better protection against vascular outcomes as aspirin – creating duplication of therapy. The increased risk of bleeds may not outweigh the negligible efficacy benefit.

Are you looking for a place to network AND get some FREE CE?  Download the CEimpact app. The app allows you to connect with pharmacy professionals, get CE, attend events, access product information and so much more - all from your mobile device.

Show Segments
00:00 - Introductions

00:58 - Aspirin Use with Anticoagulants

4:02 - Overview of Schafer et al

11:50 - The Gamechanger: Study Findings

17:48 - Connecting to Practice: DOAC Use

19:52 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health


References and Resources

• Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation

Redeem your CPE or CME here

• CPE (Pharmacist)
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss indications for cardioprotective aspirin in patients taking anticoagulants
2. Describe drawbacks to implementing the findings of the Schaefer et al study to a general patient population using anticoagulants

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-381-H01-P
Initial release date: 10/24/2022
Expiration date: 10/24/2023
Additional CPE and CME details can be found here

Follow CEimpact on Social Media:
LinkedIn
Instagram

So often, we can fall into the trap of viewing our time with experiential learners as a burden – something that takes time and energy that we feel we don’t have in a busy practice. How can you operationalize and optimize student contribution on-site, build trust among all parties, and overcome challenges and barriers that come along with experiential learning? Tune in to find out how one busy community pharmacist engaged his students to provide an exceptional learning experience that has enhanced their pharmacy-based services and improved care for patients.

Host
Kathy Schott, PhD
CEimpact
 
Guests
Anthony Bolus, PharmD
Clinical Coordinator
Family Medicine Services, Inc.
Bessemer, AB

Connect with Anthony Bolus on LinkedIn

Dr. Anthony J. Bolus has worked in community pharmacy for over 10 years since starting as a technician in 2007 in a chain store. Dr. Bolus graduated from Samford University’s McWhorter School of Pharmacy (MSOP) with a Doctor of Pharmacy degree in 2013. Upon graduation, he became a manager at a chain pharmacy in Calera, Alabama, then returned to school in 2014/2015 to complete a postgraduate year one (PGY1) community pharmacy residency with Family Medical Services (FMS), Inc. and Samford University’s MSOP. After completing the residency, Dr. Bolus was hired to be the full time clinical coordinator of FMS, Inc., a position in which he has served for over six years now. Through this position, he helps to oversee, train, and create services beyond dispensing medications at all four of the independent store locations. Dr. Bolus currently serves as a preceptor for Samford University and Auburn University pharmacy students and also in an adjunct faculty capacity at Samford. In addition, Dr. Bolus is the founder and producer of a pharmacy radio show, Healthy Dose, which he began in 2011 and ran for 10 years on Birmingham’s Smooth Jazz Radio Station FM91.1. Healthy Dose® is now a podcast available on all podcast streaming platforms. 

Get CE
Click here to access the course

CE Information

At the end of this course, preceptors will be able to:

1. Discuss opportunities and challenges associated with utilizing students in the delivery of patient care services
2. Describe some strategies for effectively utilizing students as “extenders” of patient care services

 UAN: 0107-0000-22-373-H99-P
 Release Date: 10/05/2022
 Expiration Date: 10/05/2025

 The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

• Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
• Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

 Want more information on this and related topics? Check out these courses:

• What is this Wheel? 
• Tools to Facilitate Success With Your Learning
• Managing Time as a Preceptor

Follow CEimpact on Social Media:
LinkedIn
Instagram